Drug News: June 2012
Fampyra to improve walking speed in MS; Lodalis for hypercholestrerolemia; Saphris atypical antipsychotic; Other new products (Arzerra, Durela, Luxiq, Mozobil and Zelboraf); new generics, new indications, new dosage forms and Health Canada advisories.